When the whole exceeds the sum of its parts: Squeezing greater cumulative benefit from cross-technology partnerships in bacterial infection

Better alignment between antibiotic and diagnostic development is critical to maximise clinical impact and support resistance monitoring. Public-sector support could help enable effective partnerships and improve patient outcomes.